ADVERTISEMENT
Updated July 27
Magnifying glass in front of a stack of files of papers
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy

The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.

The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.

biotech, FDA

Former FDA Commissioner Frank Young Dies
Jef Akst | Dec 2, 2019 | 2 min read
The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.
Theranos CEO Presents New Device
Kerry Grens | Aug 2, 2016 | 2 min read
The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.
Following FDA OK, 23andMe to Expand Health Prediction
Kerry Grens | Oct 21, 2015 | 2 min read
The personal genomics firm is ramping up its suite of disease-related genetic tests.
The Sounds of Silence
Jenny Rood | Sep 1, 2015 | 8 min read
Science-based tinnitus therapeutics are finally coming into their own.
FDA Approves 3-D–Printed Drug
Jef Akst | Aug 4, 2015 | 1 min read
The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.
Lazarus Drugs
Kate Yandell | Feb 1, 2015 | 8 min read
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
 
Self-prescribing Patients?
Jef Akst | Mar 13, 2012 | 1 min read
The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.
ADVERTISEMENT